These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18989988)

  • 21. Advances in imaging probes and optical microendoscopic imaging techniques for early in vivo cancer assessment.
    Khemthongcharoen N; Jolivot R; Rattanavarin S; Piyawattanametha W
    Adv Drug Deliv Rev; 2014 Jul; 74():53-74. PubMed ID: 24120351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamic biomarkers for molecular cancer therapeutics.
    Sarker D; Workman P
    Adv Cancer Res; 2007; 96():213-68. PubMed ID: 17161682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular Imaging in Drug Discovery and Development.
    Lindner JR; Link J
    Circ Cardiovasc Imaging; 2018 Feb; 11(2):e005355. PubMed ID: 29449411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular dynamics simulations and novel drug discovery.
    Liu X; Shi D; Zhou S; Liu H; Liu H; Yao X
    Expert Opin Drug Discov; 2018 Jan; 13(1):23-37. PubMed ID: 29139324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic interventions in mammalian cells; applications and uses in high-throughput screening and drug discovery.
    Hampton SL; Kinnaird AI
    Cell Biol Toxicol; 2010 Feb; 26(1):43-55. PubMed ID: 19904619
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I.
    Geromichalos GD; Alifieris CE; Geromichalou EG; Trafalis DT
    J BUON; 2016; 21(4):764-779. PubMed ID: 27685895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using quantitative systems pharmacology for novel drug discovery.
    Pérez-Nueno VI
    Expert Opin Drug Discov; 2015 Dec; 10(12):1315-31. PubMed ID: 26328768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Verification of Pharmacokinetic Approaches in Prior Drug Development].
    Iga K
    Yakugaku Zasshi; 2019; 139(3):437-460. PubMed ID: 30828023
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality by design (QbD) approach of pharmacogenomics in drug designing and formulation development for optimization of drug delivery systems.
    Gupta S; Jhawat V
    J Control Release; 2017 Jan; 245():15-26. PubMed ID: 27871989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Live-Cell High Content Screening in Drug Development.
    Esner M; Meyenhofer F; Bickle M
    Methods Mol Biol; 2018; 1683():149-164. PubMed ID: 29082492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-based approaches to antibiotic drug discovery.
    Nicola G; Abagyan R
    Curr Protoc Microbiol; 2009 Feb; Chapter 17():Unit17.2. PubMed ID: 19235149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current insights into computer-aided immunotherapeutic design strategies.
    Cai Z; Zhang G; Zhang X; Liu Y; Fu X
    Int J Immunopathol Pharmacol; 2015 Sep; 28(3):278-85. PubMed ID: 26091813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer and comparative imaging.
    LeBlanc AK
    ILAR J; 2014; 55(1):164-8. PubMed ID: 24936036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel imaging chelates for drug discovery.
    Stasiuk GJ; Faulkner S; Long NJ
    Curr Opin Pharmacol; 2012 Oct; 12(5):576-82. PubMed ID: 22884905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simple animal models for amyotrophic lateral sclerosis drug discovery.
    Patten SA; Parker JA; Wen XY; Drapeau P
    Expert Opin Drug Discov; 2016 Aug; 11(8):797-804. PubMed ID: 27249162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using imaging biomarkers to accelerate drug development and clinical trials.
    Pien HH; Fischman AJ; Thrall JH; Sorensen AG
    Drug Discov Today; 2005 Feb; 10(4):259-66. PubMed ID: 15708744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The promise of imaging biomarkers.
    Drug News Perspect; 2010 Mar; 23(2):119-23. PubMed ID: 20369077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of Combination High-Throughput Phenotypic Screening and Target Identification Methods for the Discovery of Natural Product-Based Combination Drugs.
    Isgut M; Rao M; Yang C; Subrahmanyam V; Rida PCG; Aneja R
    Med Res Rev; 2018 Mar; 38(2):504-524. PubMed ID: 28510271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integration not isolation: arguing the case for quantitative and systems pharmacology in drug discovery and development.
    Agoram BM; Demin O
    Drug Discov Today; 2011 Dec; 16(23-24):1031-6. PubMed ID: 22020181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.